2019 Annual Meeting | C203 - Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies

Wednesday 05/08/19
03:30 PM - 05:30 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Gretchen E. Tietjen, MD
Headache
Participants should be able to describe acute migraine and recognize risk factors for and treatment of medication overuse headache; discuss preventive strategies, including medications (per evidence-based guidelines), neurostimulation, and procedural treatments; and describe cognitive behavioral therapy and locate resources for patients without access to psychologists.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Advanced Practice Provider
General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:40 PM EDT Introduction Introduction
Gretchen E. Tietjen, MD
03:40 PM - 04:10 PM EDT Speaker Advances in Acute Migraine Treatment
Gretchen E. Tietjen, MD
04:10 PM - 04:40 PM EDT Speaker Advances in Preventive Strategies
Bert B. Vargas, MD, FAAN
04:40 PM - 05:10 PM EDT Speaker Behavioral Therapies for Migraine
Elizabeth Seng, PhD, Frank Andrasik
05:10 PM - 05:30 PM EDT Discussion Panel Discussion/Questions and Answers
05:30 PM - 06:00 PM EDT Discussion Continuing the Conversation
Faculty Disclosures
Gretchen E. Tietjen, MD Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has stock in Eli Lilly. An immediate family member of Dr. Vargas has stock in Pfizer. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Elizabeth Seng, PhD Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. The institution of Dr. Seng has received research support from NINDS.
Frank Andrasik No disclosure on file